最近新增的股票 (30 天)

您沒有最近查詢的記錄。
chg | %

���_B��  

(�W�����q SHA:900904)   �l�ܦ��Ѳ�  
�j�M��h900904���������G
1.32
+0.02 (1.62%)
9��19�� - ����
SHA ����Ʃ���F 1 ���� - �K�d�n��
�d�� 1.29 - 1.32
52 �g 1.08 - 1.77
�}���� 1.29
����q 16.73�U
�`���� 53.87��
���ղv 4.22
�C�ѬէQ 0.31
�ѥ� 5475.17�U
2017�~8��29��
Q2 2017 Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Earnings Release
  

����έp�ƾڻP��v

2012�~ 9�� 2011�~
�b�Q��v -13.08% 12.93%
��~�Q��v -12.14% 14.22%
��税���«e�Q�� - 18.64%
�����겣�^���v -6.08% 8.26%
�����ѥ��^���v -7.02% 9.61%
���u 190 -
CDP Score - -

�a�}

Room 613 Changfa Tower, No. 128, Weihai Road
SHANGHAI, SHA 200003
China
+86-21-53750009 (�q��)
+86-21-53750010 (�ǯu)

�����s��

²��

Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Company��s products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of oncology, antifungal, antipyretic and gynaecology. The Company's main products include cantharidin sodium vitamin B6 injection, cantharidin sodium injection and other Chinese patent drug products. The Company distributes its products in domestic market.

���Ƨ�

Taotao Zhang Chairman of the Board
�~�֡G37
Chongxia Gang Chief Financial Officer
�~�֡G59
Bin Feng General Manager, Director
�~�֡G45
Kejing Wu Secretary of the Board
�~�֡G40
Xianjia Ka Director
�~�֡G50
Yubo Xia Director
�~�֡G39
Liangshan Dong Independent Director
�~�֡G63
Xueming Zhang Independent Director
�~�֡G53
Yun Zhu Independent Director
�~�֡G67